Johnson & Johnson is five months away from starting human trials on a COVID-19 vaccine, the pharmaceutical giant said Monday
Dozens are companies and academic institutions are working on a COVID-19 vaccine. Photo: Jeff Pachoud/AFP via Getty Images We’re committed to keeping our readers informed.
Johnson & Johnson is five months away from starting human trials on a COVID-19 vaccine, the pharmaceutical giant said Monday. Clinical data would be available by the end of the year, leaving open the possibility of emergency-use authorization by early next year. The firm began working on a vaccine in January, Gorsky said, and has partnered with the federal government’s Biomedical Advanced Research and Development Authority to speed the vaccine though testing and approval. “This is a bit of a moon shot for J&J going forward, but it’s one we feel is very, very important for us to be doing at this period in time,” he said.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
Coronavirus: Germany plans COVID-19 'immunity certificates' testing - Business InsiderGermany could issue hundreds of thousands of people with coronavirus 'immunity certificates' so they can leave the lockdown early
Baca lebih lajut »
Survivalists and other self-described 'preppers' say they were ready for COVID-19Preppers in Kentucky and across the country were stocked up on supplies well before people rushed to buy toilet paper and guns and bread flour.
Baca lebih lajut »
What Is The Cost Of COVID-19 Treatment?As more Americans get COVID-19, and many more lose their jobs and their health insurance, there's another big worry: If you get sick enough to be hospitalized, how much is it going to cost?
Baca lebih lajut »
Covid-19 forces Japan to delay the OlympicsIf the pandemic is mishandled, even next year may prove too early to reschedule
Baca lebih lajut »